CD63 and breast cancer: The downregulation of tetraspanin CD63- or CD9-positive EVs by paclitaxel was also observed in MDA-MB-231 and HCC1937 breast cancer cells (89), implying that non-exosomal EV subtypes could be generated by paclitaxel.